More Business Wire
View Older Stories View Newer Stories-
Bain Capital and 11North Partners Acquire Five Open-Air Retail Centers for $300 Million
-
bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology
-
Momentus Announces Pricing of a $25 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules with Existing Fundamental Institutional Investors
-
Coya Therapeutics to Present ALSTARS Trial Design at the 5th ALS Drug Development Summit
-
Kemper Announces Appointment of Stephen J. McAnena as President, Chief Executive Officer and Board Member
-
Immunome to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
-
Foray Bioscience Launches Pando, an Intelligent Research & Development Workspace for Plant Biology
-
Silence Therapeutics to Participate in Jefferies Global Healthcare Conference
-
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
-
Radienz Living Announces CPG Executive Christopher Kodosky Joins as Chief Financial Officer
-
Retension Pharmaceuticals Appoints Alison Schecter, M.D., as Chief Medical Officer and Alex Schwartz as Chief Financial Officer
-
AUA 2026 Data Reinforce Procedural Efficiency, Stone Clearance, and Safety of the CVAC System in the Real World
-
ICE's Total Futures and Options at Record Open Interest as Global Natural Gas and Power Markets Reach Record Levels of Liquidity
-
Parse Biosciences and bit.bio Announce Landmark Alliance
-
KnowBe4 Enables Organizations to Have Independent Control Over Outbound Email Security
-
North America Lags in Productization and DfMA Adoption, but Momentum Is Building
-
InduPro Therapeutics Appoints Amanda J. Redig, MD, PhD, as Chief Medical Officer
-
Member Satisfaction Holds Steady as Commercial Health Plans Focus on Improving Trust, Claims and Cost Stability, JD Power Finds
-
Palleon Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of E-688/HLX316, a First-in-Class B7-H3-Targeted Sialidase for Advanced Solid Tumors
-
Cardiosense Receives FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure
-
Ankyra Therapeutics Announces Presentations on Novel IL-12 Anchored Immunotherapy at 2026 ASCO
-
Suffolk Expands West Coast Aviation Leadership With Hiring of Emery Molnar and Elevates Sam Sleiman to National President of Transportation
-
Nielsen BioSciences Announces Positive Phase 3 Trial Results of CANDIN for the Treatment and Clearance of Common Warts
-
Infleqtion to Present at Evercore TMT Conference
-
VantageScore CreditGauge™ April 2026: Consumers Borrow Selectively as Delinquencies Ease and Mortgage Demand Strengthens
-
Post Oak Energy Capital Announces Sale of NGNV and Quantent’s Haynesville Assets
-
LCI Industries Announces Participation in Stifel Cross Sector Conference
-
eSentire Advances Controlled Autonomy SecOps with Agentic AI That Preempts, Detects, and Responds in a Single Unified Platform
-
Box to Present at Investor Conferences
-
TPG to Present at the Morgan Stanley U.S. Financials Conference
-
ONDEX Automation Acquires The Fitch Company to Deepen Process Automation and Design Capabilities
-
Milliman expands life insurance ALM services with new SAA solution
-
Member Satisfaction Holds Steady as Commercial Health Plans Focus on Improving Trust, Claims and Cost Stability
-
MindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage
-
Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
-
Children’s Minnesota Names Sameer Gupta, M.D., MBA, Executive Vice President and Chief Medical Officer
-
TrueBlue Board of Directors Unanimously Rejects Unsolicited Proposal from HireQuest for On-Demand Business
-
Ollin Biosciences to Participate in Upcoming Investor Conferences
-
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
-
Corcept to Resubmit its New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome
-
Fortem Technologies Establishes Government Advisory Board Led by MG (Ret.) Clay Hutmacher
-
Backstory Appoints Victor Chang as Chief Information Security Officer to Usher in Global Security for Its AI Answers Platform
-
Arima Genomics Announces Presentation of New Data at ASCO 2026 Supporting Clinical Utility of Hi-C Sequencing in Non-Small Cell Lung Cancer
-
Itera Exits Stealth With $12M to Bring Real-Time Prototyping to Electronics
-
Lightcurve Launches Ultra-Fast 8 Gig Fiber Internet Service Across Central Washington
-
Redfin Reports 29% of U.S. Homebuyers Paid Cash in March—the Lowest Share For That Month Since 2020
-
Powerlaw Corp. Begins Trading on Nasdaq as PWRL
-
Lockhart, Morris & Montgomery Inc. (LMM) and Overtime Announce Strategic Partnership to Advance AI in Collections
-
Love: Why Consumers Pay More
-
LexAxiom Announces LexSuite, an Agentic Revenue Engine for Solo, Small, and Mid-Size Law Firms
